Predict your next investment

Little Sparrows Technologies company logo
HEALTHCARE | Medical Devices & Equipment / Patient Monitoring
little-sparrows-tech.com

See what CB Insights has to offer

Stage

Grant | Alive

Total Raised

$50K

Last Raised

$50K | 8 yrs ago

About Little Sparrows Technologies

Little Sparrows Technologies makes low-cost, power-adaptable phototherapy devices to cure babies with jaundice in low resource areas

Little Sparrows Technologies Headquarter Location

21 Drydock Ave

Boston, Massachusetts, 02210,

United States

781-725-2460

Latest Little Sparrows Technologies News

Little Sparrows Technologies Receives FDA Clearance for an Innovative Portable Medical Device for Treating Infant Jaundice

Sep 18, 2019

Little Sparrows Technologies , a neonatal medical device startup committed to promoting the well-being of newborns, announced today it has received 510(k) clearance from the Food and Drug Administration (FDA) for the bili-hut™. The bili-hut is an innovative ultraportable neonatal phototherapy system that leverages a bassinet-like design to treat hyperbilirubinemia, commonly known as neonatal jaundice. The device features a unique curved light emitting diode (LED) illumination canopy that delivers high-intensity blue light phototherapy. This highly portable device allows newborns to effectively undergo jaundice treatment anywhere – at home or in a hospital setting. “Neonatal jaundice is very common and is often diagnosed when a newborn is almost ready for discharge from the hospital or after the baby is home for a few days, requiring longer hospital stays or readmittance,” said Dr. Donna Brezinski, CEO and founder, Little Sparrow Technologies. “Phototherapy treatment typically occurs in NICUs, which separates newborns from their mothers who are bonding and establishing breast feeding. The bili-hut provides the best possible start for jaundiced babies by enabling treatment at the mother’s side, whether in the hospital or at home.” Neonatal jaundice is a transitional phenomenon which affects three out of five newborns in their first weeks of life. Jaundice causes a yellow discoloration of the skin and eyes in newborns and typically subsides within a few days. In newborns with severe jaundice, blue light phototherapy is required to prevent irreversible neurologic injury. Jaundice is also one of the most common diagnoses associated with infant readmission to a hospital in the first month of life. In the United States, it is estimated that 100,000 infants develop severe jaundice, costing the healthcare systems $500M annually for hospital-based care. Hospital phototherapy devices can be daunting for new parents and extended hospital stays are often stressful and expensive. Invented by Dr. Brezinski, a neonatal-perinatal specialist, the bili-hut is capable of delivering hospital intensity phototherapy at the parent’s bedside in either the postpartum room or at home, presenting a new, innovative and cost-effective approach to addressing the challenges of treating jaundice. With the bili-hut doctors can improve the quality of care for infants by maintaining a close relationship with parents while helping to reduce emergency room visits and readmissions. The bili-hut will be on display at the Little Sparrows Technologies booth #133 at the 2019 American Academy of Pediatrics National Conference & Exhibition in New Orleans, October 26-28. For more information on the bili-hut, visit http://www.little-sparrows-tech.com . About Little Sparrows Technologies Founded in 2013 by Harvard Medical School affiliated doctors, Little Sparrows Technologies offers an innovative approach for treating jaundice. The bili-hut™ is a cost-effective phototherapy device that uses blue LED lights in a reflective bassinet that is capable of operation on battery power. It is simple to use and collapsible for easy transport. Little Sparrows has received two phases of funding from the NIH’s Small Business Innovation Research (SBIR) program, and The World Health Organization included the bili-hut in its Compendium of Medical Devices for Global Health. Little Sparrows Technologies was the winner of a 2018 Patents for Humanity Award. The company offers solutions to support hospitals, US pediatrician offices and international implementations. For more information, visit http://www.little-sparrows-tech.com . For the original version on PRWeb visit: https://www.prweb.com/releases/little_sparrows_technologies_receives_fda_clearance_for_an_innovative_portable_medical_device_for_treating_infant_jaundice/prweb16578084.htm

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Little Sparrows Technologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Little Sparrows Technologies is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

3,045 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

Little Sparrows Technologies Patents

Little Sparrows Technologies has filed 2 patents.

The 3 most popular patent topics include:

  • Hepatology
  • Neonatology
  • Pediatrics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/29/2016

6/1/2021

Hepatology, Pediatrics, Neonatology, Psychiatric diagnosis, Radiation therapy

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

6/29/2016

00/00/0000

Grant Date

6/1/2021

00/00/0000

Title

Subscribe to see more

Related Topics

Hepatology, Pediatrics, Neonatology, Psychiatric diagnosis, Radiation therapy

Subscribe to see more

Status

Grant

Subscribe to see more

Little Sparrows Technologies Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Little Sparrows Technologies Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.